Atlas Trials

Boston Pharmaceuticals

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Boston Pharmaceuticals

RecordFirmDate
Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test (NCT04221906)Boston Pharmaceuticals2020-01-06
Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris (NCT04163263)Boston Pharmaceuticals2019-11-04
Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects (NCT04514237)Boston Pharmaceuticals2019-09-12
Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) (NCT03977155)Boston Pharmaceuticals2019-06-04
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis (NCT03960450)Boston Pharmaceuticals2019-04-23
Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors (NCT03780517)Boston Pharmaceuticals2018-12-12
Study to Determine the Single and Repeat Dose Pharmacokinetics, Food Effect, Proton Pump Inhibitor (PPI) Drug Interaction, Safety and Tolerability of Oral Prototype Formulations of BOS172767 in Healthy Subjects (NCT03464058)Boston Pharmaceuticals2018-03-21
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care (NCT03371251)Boston Pharmaceuticals2018-01-10
Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies (NCT03328494)Boston Pharmaceuticals2017-10-13

Track Boston Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.